These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations. Skolnik K; Quon BS F1000Res; 2018; 7():. PubMed ID: 29862015 [TBL] [Abstract][Full Text] [Related]
52. Cancer risk among patients with cystic fibrosis. Neglia JP; Wielinski CL; Warwick WJ J Pediatr; 1991 Nov; 119(5):764-6. PubMed ID: 1941382 [No Abstract] [Full Text] [Related]
53. Understanding and managing poor adherence in cystic fibrosis. Lask B Pediatr Pulmonol Suppl; 1997; 16():260-1. PubMed ID: 9443303 [No Abstract] [Full Text] [Related]
54. Isolation of Sporosarcina ureae from a bronchial biopsy in a child with cystic fibrosis. Chomarat M; de Montclos M; Flandrois JP; Breysse F Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):302-3. PubMed ID: 2351147 [No Abstract] [Full Text] [Related]
56. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Whiting P; Al M; Burgers L; Westwood M; Ryder S; Hoogendoorn M; Armstrong N; Allen A; Severens H; Kleijnen J Health Technol Assess; 2014 Mar; 18(18):1-106. PubMed ID: 24656117 [TBL] [Abstract][Full Text] [Related]
57. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566 [TBL] [Abstract][Full Text] [Related]
59. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821 [TBL] [Abstract][Full Text] [Related]
60. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Sanders DB; Bittner RC; Rosenfeld M; Redding GJ; Goss CH Pediatr Pulmonol; 2011 Apr; 46(4):393-400. PubMed ID: 20967845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]